GLUE: Monte Rosa Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Monte Rosa Therapeutics Inc. is a biotechnology company. It involved in developing a portfolio of novel small molecule precision medicines which employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. Monte Rosa Therapeutics Inc. is based in BOSTON.

Info & Links

CEO

Markus Warmuth

Headquarters

321 HARRISON AVENUE, SUITE 900
BOSTON, MA 02118, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

134

Employees

134

Monte Rosa Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

280.18M

Enterprise Value

55.92M

Enterprise Value/EBITDA(ttm)

-0.77

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

1.98

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

Profit Margin(ttm)

-971.71%

Return on Equity(ttm)

-62.68%

Return on Invested Capital(ttm)

-40.04%

Return on Assets(ttm)

-38.83%

Income Statement

Revenue(ttm)

75.62M

Revenue Per Share(ttm)

1.23

Gross Profit(ttm)

75.62M

EBITDA(ttm)³

-72.99M

Net Income Available to Common(ttm)

-72.70M

Diluted EPS(ttm)

-1.83

Share Statistics

Beta (5Y Monthly)

1.46

52-Week Change

-23.01%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

61.51M

Dividend Yield

0.00%

Float⁴

57.44M

% Held by Insiders

6.50%

% Held by Institutions

79.96%

Balance Sheet

Total Cash(mrq)

372.15M

Total Cash Per Share(mrq)

6.05

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.40%

Quick Ratio(mrq)

6.03%

Book Value Per Share(mrq)

3.62

Cash Flow

Operating Cash Flow Per Share(ytd)

0.57

Free Cash Flow(ytd)

38.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

GLUE

Monte Rosa Therapeutics, Inc. Common Stock

Monte Rosa Therapeutics, Inc. Common Stock Profile